Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

(6826)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shanghai Haohai Biological Technology : Projects Up to 193% Growth in January-September Profit

10/18/2021 | 05:38am EST


ę MT Newswires 2021
All news about SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
2021Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 3,..
CI
2021SHANGHAI HAOHAI BIOLOGICAL TECHNOLOG : 688366) added to Shanghai Stock Exchange Health Car..
CI
2021Haohai Biological Buys 51% Stake in Contact Lens Maker for $11 Million
MT
2021Shanghai Haohai Biological Technology's Q3 Profit Drops 6.6% as R&D Expenses Rise
MT
2021Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine M..
CI
2021SHANGHAI HAOHAI BIOLOGICAL TECHNOLOG : Projects Up to 193% Growth in January-September Pro..
MT
2021Shanghai Haohai Biological Technology Co., Ltd. Provides Group Earnings Guidance for th..
CI
2021SHANGHAI HAOHAI BIOLOGICAL TECHNOLOG : 688366) added to S&P Global BMI Index
CI
2021SHANGHAI HAOHAI BIOLOGICAL TECHNOLOG : Haohai Biological Technology's H1 Profit Leaps 739%..
MT
2021Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan..
CI
More news
Financials
Sales 2021 1 889 M 299 M 299 M
Net income 2021 474 M 75,0 M 75,0 M
Net cash 2021 3 276 M 518 M 518 M
P/E ratio 2021 18,4x
Yield 2021 1,49%
Capitalization 19 771 M 2 540 M 3 128 M
EV / Sales 2021 8,73x
EV / Sales 2022 7,06x
Nbr of Employees 1 374
Free-Float 38,5%
Chart SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Duration : Period :
Shanghai Haohai Biological Technology Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 50,00 CNY
Average target price 92,92 CNY
Spread / Average Target 85,8%
EPS Revisions
Managers and Directors
Jian Ying Wu General Manager & Director
Min Jie Tang Chief Financial Officer & Executive Director
Yong Tai Hou Chairman
Yuan Zhong Liu Chairman-Supervisory Board
Chang Zheng Wei Deputy Manager-Research & Development
Sector and Competitors